nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—SLC22A8—Conjugated Estrogens—osteoporosis	0.0439	0.076	CbGbCtD
Valproic Acid—SLC22A8—Estradiol—osteoporosis	0.0385	0.0668	CbGbCtD
Valproic Acid—CYP2B6—Raloxifene—osteoporosis	0.0374	0.0649	CbGbCtD
Valproic Acid—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0362	0.0627	CbGbCtD
Valproic Acid—CYP1A2—Estropipate—osteoporosis	0.0329	0.0571	CbGbCtD
Valproic Acid—SLC22A6—Conjugated Estrogens—osteoporosis	0.0305	0.053	CbGbCtD
Valproic Acid—CYP2C9—Estropipate—osteoporosis	0.0297	0.0514	CbGbCtD
Valproic Acid—CYP2B6—Cholecalciferol—osteoporosis	0.0289	0.0501	CbGbCtD
Valproic Acid—CYP2C8—Raloxifene—osteoporosis	0.0284	0.0492	CbGbCtD
Valproic Acid—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0274	0.0475	CbGbCtD
Valproic Acid—CYP2C8—Cholecalciferol—osteoporosis	0.0219	0.038	CbGbCtD
Valproic Acid—CYP2C19—Cholecalciferol—osteoporosis	0.0184	0.0319	CbGbCtD
Valproic Acid—CYP3A5—Estradiol—osteoporosis	0.0184	0.0318	CbGbCtD
Valproic Acid—CYP2C8—Estradiol—osteoporosis	0.0177	0.0306	CbGbCtD
Valproic Acid—CYP3A4—Estropipate—osteoporosis	0.0172	0.0299	CbGbCtD
Valproic Acid—CYP3A4—Calcitriol—osteoporosis	0.0172	0.0299	CbGbCtD
Valproic Acid—CYP1A2—Conjugated Estrogens—osteoporosis	0.0156	0.027	CbGbCtD
Valproic Acid—CYP2C9—Cholecalciferol—osteoporosis	0.0153	0.0265	CbGbCtD
Valproic Acid—CYP2C19—Estradiol—osteoporosis	0.0148	0.0257	CbGbCtD
Valproic Acid—CYP3A4—Ergocalciferol—osteoporosis	0.0138	0.0239	CbGbCtD
Valproic Acid—CYP1A2—Estradiol—osteoporosis	0.0137	0.0237	CbGbCtD
Valproic Acid—CYP2C9—Estradiol—osteoporosis	0.0123	0.0213	CbGbCtD
Valproic Acid—CYP3A4—Raloxifene—osteoporosis	0.0115	0.0199	CbGbCtD
Valproic Acid—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0111	0.0193	CbGbCtD
Valproic Acid—CYP3A4—Cholecalciferol—osteoporosis	0.00888	0.0154	CbGbCtD
Valproic Acid—CYP3A4—Conjugated Estrogens—osteoporosis	0.00815	0.0141	CbGbCtD
Valproic Acid—CYP3A4—Estradiol—osteoporosis	0.00716	0.0124	CbGbCtD
Valproic Acid—HDAC2—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000833	1	CbGdCrCtD
Valproic Acid—Hypersensitivity—Ibandronate—osteoporosis	0.000142	0.000465	CcSEcCtD
Valproic Acid—Cough—Conjugated Estrogens—osteoporosis	0.000142	0.000465	CcSEcCtD
Valproic Acid—Dyspnoea—Risedronate—osteoporosis	0.000142	0.000464	CcSEcCtD
Valproic Acid—Erythema multiforme—Estradiol—osteoporosis	0.000142	0.000464	CcSEcCtD
Valproic Acid—Hypotension—Pamidronate—osteoporosis	0.000141	0.000463	CcSEcCtD
Valproic Acid—Dry mouth—Zoledronate—osteoporosis	0.000141	0.000461	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000141	0.000461	CcSEcCtD
Valproic Acid—Fatigue—Ethinyl Estradiol—osteoporosis	0.000141	0.00046	CcSEcCtD
Valproic Acid—Pruritus—Alendronate—osteoporosis	0.00014	0.000459	CcSEcCtD
Valproic Acid—Dyspepsia—Risedronate—osteoporosis	0.00014	0.000458	CcSEcCtD
Valproic Acid—Eye disorder—Estradiol—osteoporosis	0.00014	0.000458	CcSEcCtD
Valproic Acid—Tinnitus—Estradiol—osteoporosis	0.00014	0.000457	CcSEcCtD
Valproic Acid—Constipation—Ethinyl Estradiol—osteoporosis	0.00014	0.000457	CcSEcCtD
Valproic Acid—Confusional state—Zoledronate—osteoporosis	0.000139	0.000456	CcSEcCtD
Valproic Acid—Hypersensitivity—Calcitriol—osteoporosis	0.000139	0.000456	CcSEcCtD
Valproic Acid—Myalgia—Conjugated Estrogens—osteoporosis	0.000139	0.000454	CcSEcCtD
Valproic Acid—Arthralgia—Conjugated Estrogens—osteoporosis	0.000139	0.000454	CcSEcCtD
Valproic Acid—Chest pain—Conjugated Estrogens—osteoporosis	0.000139	0.000454	CcSEcCtD
Valproic Acid—Asthenia—Ibandronate—osteoporosis	0.000139	0.000453	CcSEcCtD
Valproic Acid—Anxiety—Conjugated Estrogens—osteoporosis	0.000138	0.000453	CcSEcCtD
Valproic Acid—Nausea—Etidronic acid—osteoporosis	0.000138	0.000452	CcSEcCtD
Valproic Acid—Anaphylactic shock—Zoledronate—osteoporosis	0.000138	0.000452	CcSEcCtD
Valproic Acid—Oedema—Zoledronate—osteoporosis	0.000138	0.000452	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000138	0.000451	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000138	0.000451	CcSEcCtD
Valproic Acid—Diarrhoea—Estropipate—osteoporosis	0.000138	0.000451	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Risedronate—osteoporosis	0.000137	0.00045	CcSEcCtD
Valproic Acid—Infection—Zoledronate—osteoporosis	0.000137	0.000449	CcSEcCtD
Valproic Acid—Fatigue—Risedronate—osteoporosis	0.000137	0.000449	CcSEcCtD
Valproic Acid—Insomnia—Pamidronate—osteoporosis	0.000137	0.000448	CcSEcCtD
Valproic Acid—Pruritus—Ibandronate—osteoporosis	0.000137	0.000447	CcSEcCtD
Valproic Acid—Constipation—Risedronate—osteoporosis	0.000136	0.000445	CcSEcCtD
Valproic Acid—Pain—Risedronate—osteoporosis	0.000136	0.000445	CcSEcCtD
Valproic Acid—Angiopathy—Estradiol—osteoporosis	0.000136	0.000445	CcSEcCtD
Valproic Acid—Paraesthesia—Pamidronate—osteoporosis	0.000136	0.000444	CcSEcCtD
Valproic Acid—Diarrhoea—Alendronate—osteoporosis	0.000136	0.000444	CcSEcCtD
Valproic Acid—Asthenia—Calcitriol—osteoporosis	0.000136	0.000444	CcSEcCtD
Valproic Acid—Nervous system disorder—Zoledronate—osteoporosis	0.000136	0.000443	CcSEcCtD
Valproic Acid—Immune system disorder—Estradiol—osteoporosis	0.000135	0.000443	CcSEcCtD
Valproic Acid—Thrombocytopenia—Zoledronate—osteoporosis	0.000135	0.000443	CcSEcCtD
Valproic Acid—Mediastinal disorder—Estradiol—osteoporosis	0.000135	0.000442	CcSEcCtD
Valproic Acid—Dyspnoea—Pamidronate—osteoporosis	0.000135	0.000441	CcSEcCtD
Valproic Acid—Tachycardia—Zoledronate—osteoporosis	0.000135	0.000441	CcSEcCtD
Valproic Acid—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000135	0.00044	CcSEcCtD
Valproic Acid—Chills—Estradiol—osteoporosis	0.000134	0.00044	CcSEcCtD
Valproic Acid—Somnolence—Pamidronate—osteoporosis	0.000134	0.00044	CcSEcCtD
Valproic Acid—Skin disorder—Zoledronate—osteoporosis	0.000134	0.000439	CcSEcCtD
Valproic Acid—Pruritus—Calcitriol—osteoporosis	0.000134	0.000438	CcSEcCtD
Valproic Acid—Hyperhidrosis—Zoledronate—osteoporosis	0.000134	0.000437	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000133	0.000437	CcSEcCtD
Valproic Acid—Diarrhoea—Raloxifene—osteoporosis	0.000133	0.000437	CcSEcCtD
Valproic Acid—Dyspepsia—Pamidronate—osteoporosis	0.000133	0.000436	CcSEcCtD
Valproic Acid—Dizziness—Estropipate—osteoporosis	0.000133	0.000436	CcSEcCtD
Valproic Acid—Oedema—Conjugated Estrogens—osteoporosis	0.000133	0.000435	CcSEcCtD
Valproic Acid—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000133	0.000435	CcSEcCtD
Valproic Acid—Alopecia—Estradiol—osteoporosis	0.000132	0.000433	CcSEcCtD
Valproic Acid—Infection—Conjugated Estrogens—osteoporosis	0.000132	0.000432	CcSEcCtD
Valproic Acid—Diarrhoea—Ibandronate—osteoporosis	0.000132	0.000432	CcSEcCtD
Valproic Acid—Anorexia—Zoledronate—osteoporosis	0.000132	0.000431	CcSEcCtD
Valproic Acid—Decreased appetite—Pamidronate—osteoporosis	0.000132	0.00043	CcSEcCtD
Valproic Acid—Mental disorder—Estradiol—osteoporosis	0.000131	0.00043	CcSEcCtD
Valproic Acid—Dizziness—Alendronate—osteoporosis	0.000131	0.000429	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000131	0.000427	CcSEcCtD
Valproic Acid—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00013	0.000427	CcSEcCtD
Valproic Acid—Malnutrition—Estradiol—osteoporosis	0.00013	0.000427	CcSEcCtD
Valproic Acid—Fatigue—Pamidronate—osteoporosis	0.00013	0.000427	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Risedronate—osteoporosis	0.00013	0.000426	CcSEcCtD
Valproic Acid—Tachycardia—Conjugated Estrogens—osteoporosis	0.00013	0.000425	CcSEcCtD
Valproic Acid—Urticaria—Ethinyl Estradiol—osteoporosis	0.00013	0.000424	CcSEcCtD
Valproic Acid—Pain—Pamidronate—osteoporosis	0.000129	0.000423	CcSEcCtD
Valproic Acid—Constipation—Pamidronate—osteoporosis	0.000129	0.000423	CcSEcCtD
Valproic Acid—Diarrhoea—Calcitriol—osteoporosis	0.000129	0.000423	CcSEcCtD
Valproic Acid—Skin disorder—Conjugated Estrogens—osteoporosis	0.000129	0.000423	CcSEcCtD
Valproic Acid—Hypotension—Zoledronate—osteoporosis	0.000129	0.000422	CcSEcCtD
Valproic Acid—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000129	0.000422	CcSEcCtD
Valproic Acid—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000129	0.000422	CcSEcCtD
Valproic Acid—Dizziness—Raloxifene—osteoporosis	0.000129	0.000422	CcSEcCtD
Valproic Acid—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000129	0.000421	CcSEcCtD
Valproic Acid—Flatulence—Estradiol—osteoporosis	0.000129	0.000421	CcSEcCtD
Valproic Acid—Tension—Estradiol—osteoporosis	0.000128	0.000419	CcSEcCtD
Valproic Acid—Vomiting—Estropipate—osteoporosis	0.000128	0.000419	CcSEcCtD
Valproic Acid—Dysgeusia—Estradiol—osteoporosis	0.000128	0.000418	CcSEcCtD
Valproic Acid—Dizziness—Ibandronate—osteoporosis	0.000128	0.000418	CcSEcCtD
Valproic Acid—Rash—Estropipate—osteoporosis	0.000127	0.000415	CcSEcCtD
Valproic Acid—Dermatitis—Estropipate—osteoporosis	0.000127	0.000415	CcSEcCtD
Valproic Acid—Anorexia—Conjugated Estrogens—osteoporosis	0.000127	0.000415	CcSEcCtD
Valproic Acid—Nervousness—Estradiol—osteoporosis	0.000127	0.000415	CcSEcCtD
Valproic Acid—Urticaria—Risedronate—osteoporosis	0.000126	0.000414	CcSEcCtD
Valproic Acid—Back pain—Estradiol—osteoporosis	0.000126	0.000413	CcSEcCtD
Valproic Acid—Headache—Estropipate—osteoporosis	0.000126	0.000413	CcSEcCtD
Valproic Acid—Vomiting—Alendronate—osteoporosis	0.000126	0.000413	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000126	0.000412	CcSEcCtD
Valproic Acid—Body temperature increased—Risedronate—osteoporosis	0.000126	0.000412	CcSEcCtD
Valproic Acid—Abdominal pain—Risedronate—osteoporosis	0.000126	0.000412	CcSEcCtD
Valproic Acid—Muscle spasms—Estradiol—osteoporosis	0.000125	0.00041	CcSEcCtD
Valproic Acid—Rash—Alendronate—osteoporosis	0.000125	0.000409	CcSEcCtD
Valproic Acid—Insomnia—Zoledronate—osteoporosis	0.000125	0.000409	CcSEcCtD
Valproic Acid—Dermatitis—Alendronate—osteoporosis	0.000125	0.000409	CcSEcCtD
Valproic Acid—Feeling abnormal—Pamidronate—osteoporosis	0.000125	0.000408	CcSEcCtD
Valproic Acid—Hypotension—Conjugated Estrogens—osteoporosis	0.000124	0.000407	CcSEcCtD
Valproic Acid—Headache—Alendronate—osteoporosis	0.000124	0.000407	CcSEcCtD
Valproic Acid—Paraesthesia—Zoledronate—osteoporosis	0.000124	0.000406	CcSEcCtD
Valproic Acid—Vomiting—Raloxifene—osteoporosis	0.000124	0.000406	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Pamidronate—osteoporosis	0.000124	0.000405	CcSEcCtD
Valproic Acid—Dyspnoea—Zoledronate—osteoporosis	0.000123	0.000403	CcSEcCtD
Valproic Acid—Rash—Raloxifene—osteoporosis	0.000123	0.000402	CcSEcCtD
Valproic Acid—Dermatitis—Raloxifene—osteoporosis	0.000123	0.000402	CcSEcCtD
Valproic Acid—Somnolence—Zoledronate—osteoporosis	0.000123	0.000402	CcSEcCtD
Valproic Acid—Vomiting—Ibandronate—osteoporosis	0.000123	0.000402	CcSEcCtD
Valproic Acid—Tremor—Estradiol—osteoporosis	0.000122	0.0004	CcSEcCtD
Valproic Acid—Headache—Raloxifene—osteoporosis	0.000122	0.0004	CcSEcCtD
Valproic Acid—Rash—Ibandronate—osteoporosis	0.000122	0.000398	CcSEcCtD
Valproic Acid—Dermatitis—Ibandronate—osteoporosis	0.000122	0.000398	CcSEcCtD
Valproic Acid—Dyspepsia—Zoledronate—osteoporosis	0.000122	0.000398	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000121	0.000397	CcSEcCtD
Valproic Acid—Ill-defined disorder—Estradiol—osteoporosis	0.000121	0.000396	CcSEcCtD
Valproic Acid—Headache—Ibandronate—osteoporosis	0.000121	0.000396	CcSEcCtD
Valproic Acid—Insomnia—Conjugated Estrogens—osteoporosis	0.00012	0.000394	CcSEcCtD
Valproic Acid—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00012	0.000393	CcSEcCtD
Valproic Acid—Vomiting—Calcitriol—osteoporosis	0.00012	0.000393	CcSEcCtD
Valproic Acid—Decreased appetite—Zoledronate—osteoporosis	0.00012	0.000393	CcSEcCtD
Valproic Acid—Agitation—Estradiol—osteoporosis	0.00012	0.000392	CcSEcCtD
Valproic Acid—Nausea—Estropipate—osteoporosis	0.00012	0.000391	CcSEcCtD
Valproic Acid—Body temperature increased—Pamidronate—osteoporosis	0.00012	0.000391	CcSEcCtD
Valproic Acid—Abdominal pain—Pamidronate—osteoporosis	0.00012	0.000391	CcSEcCtD
Valproic Acid—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000119	0.000391	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000119	0.00039	CcSEcCtD
Valproic Acid—Angioedema—Estradiol—osteoporosis	0.000119	0.00039	CcSEcCtD
Valproic Acid—Rash—Calcitriol—osteoporosis	0.000119	0.00039	CcSEcCtD
Valproic Acid—Fatigue—Zoledronate—osteoporosis	0.000119	0.00039	CcSEcCtD
Valproic Acid—Dermatitis—Calcitriol—osteoporosis	0.000119	0.00039	CcSEcCtD
Valproic Acid—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000119	0.000388	CcSEcCtD
Valproic Acid—Headache—Calcitriol—osteoporosis	0.000118	0.000387	CcSEcCtD
Valproic Acid—Somnolence—Conjugated Estrogens—osteoporosis	0.000118	0.000387	CcSEcCtD
Valproic Acid—Constipation—Zoledronate—osteoporosis	0.000118	0.000387	CcSEcCtD
Valproic Acid—Pain—Zoledronate—osteoporosis	0.000118	0.000387	CcSEcCtD
Valproic Acid—Nausea—Alendronate—osteoporosis	0.000118	0.000385	CcSEcCtD
Valproic Acid—Malaise—Estradiol—osteoporosis	0.000118	0.000385	CcSEcCtD
Valproic Acid—Hypersensitivity—Risedronate—osteoporosis	0.000117	0.000384	CcSEcCtD
Valproic Acid—Vertigo—Estradiol—osteoporosis	0.000117	0.000384	CcSEcCtD
Valproic Acid—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000117	0.000383	CcSEcCtD
Valproic Acid—Asthenia—Ethinyl Estradiol—osteoporosis	0.000117	0.000383	CcSEcCtD
Valproic Acid—Nausea—Raloxifene—osteoporosis	0.000116	0.000379	CcSEcCtD
Valproic Acid—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000116	0.000378	CcSEcCtD
Valproic Acid—Pruritus—Ethinyl Estradiol—osteoporosis	0.000115	0.000378	CcSEcCtD
Valproic Acid—Palpitations—Estradiol—osteoporosis	0.000115	0.000377	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000115	0.000376	CcSEcCtD
Valproic Acid—Fatigue—Conjugated Estrogens—osteoporosis	0.000115	0.000375	CcSEcCtD
Valproic Acid—Nausea—Ibandronate—osteoporosis	0.000115	0.000375	CcSEcCtD
Valproic Acid—Asthenia—Risedronate—osteoporosis	0.000114	0.000374	CcSEcCtD
Valproic Acid—Feeling abnormal—Zoledronate—osteoporosis	0.000114	0.000373	CcSEcCtD
Valproic Acid—Cough—Estradiol—osteoporosis	0.000114	0.000373	CcSEcCtD
Valproic Acid—Pain—Conjugated Estrogens—osteoporosis	0.000114	0.000372	CcSEcCtD
Valproic Acid—Constipation—Conjugated Estrogens—osteoporosis	0.000114	0.000372	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Zoledronate—osteoporosis	0.000113	0.00037	CcSEcCtD
Valproic Acid—Hypertension—Estradiol—osteoporosis	0.000113	0.000369	CcSEcCtD
Valproic Acid—Pruritus—Risedronate—osteoporosis	0.000113	0.000368	CcSEcCtD
Valproic Acid—Nausea—Calcitriol—osteoporosis	0.000112	0.000367	CcSEcCtD
Valproic Acid—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000112	0.000365	CcSEcCtD
Valproic Acid—Hypersensitivity—Pamidronate—osteoporosis	0.000111	0.000365	CcSEcCtD
Valproic Acid—Chest pain—Estradiol—osteoporosis	0.000111	0.000363	CcSEcCtD
Valproic Acid—Arthralgia—Estradiol—osteoporosis	0.000111	0.000363	CcSEcCtD
Valproic Acid—Myalgia—Estradiol—osteoporosis	0.000111	0.000363	CcSEcCtD
Valproic Acid—Anxiety—Estradiol—osteoporosis	0.000111	0.000362	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00011	0.000361	CcSEcCtD
Valproic Acid—Urticaria—Zoledronate—osteoporosis	0.00011	0.000359	CcSEcCtD
Valproic Acid—Discomfort—Estradiol—osteoporosis	0.00011	0.000359	CcSEcCtD
Valproic Acid—Body temperature increased—Zoledronate—osteoporosis	0.000109	0.000357	CcSEcCtD
Valproic Acid—Abdominal pain—Zoledronate—osteoporosis	0.000109	0.000357	CcSEcCtD
Valproic Acid—Diarrhoea—Risedronate—osteoporosis	0.000109	0.000356	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000109	0.000356	CcSEcCtD
Valproic Acid—Dry mouth—Estradiol—osteoporosis	0.000109	0.000355	CcSEcCtD
Valproic Acid—Asthenia—Pamidronate—osteoporosis	0.000109	0.000355	CcSEcCtD
Valproic Acid—Dizziness—Ethinyl Estradiol—osteoporosis	0.000108	0.000353	CcSEcCtD
Valproic Acid—Confusional state—Estradiol—osteoporosis	0.000107	0.000351	CcSEcCtD
Valproic Acid—Pruritus—Pamidronate—osteoporosis	0.000107	0.00035	CcSEcCtD
Valproic Acid—Oedema—Estradiol—osteoporosis	0.000106	0.000348	CcSEcCtD
Valproic Acid—Anaphylactic shock—Estradiol—osteoporosis	0.000106	0.000348	CcSEcCtD
Valproic Acid—Infection—Estradiol—osteoporosis	0.000106	0.000346	CcSEcCtD
Valproic Acid—Urticaria—Conjugated Estrogens—osteoporosis	0.000106	0.000346	CcSEcCtD
Valproic Acid—Dizziness—Risedronate—osteoporosis	0.000105	0.000344	CcSEcCtD
Valproic Acid—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000105	0.000344	CcSEcCtD
Valproic Acid—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000105	0.000344	CcSEcCtD
Valproic Acid—Nervous system disorder—Estradiol—osteoporosis	0.000104	0.000342	CcSEcCtD
Valproic Acid—Tachycardia—Estradiol—osteoporosis	0.000104	0.00034	CcSEcCtD
Valproic Acid—Vomiting—Ethinyl Estradiol—osteoporosis	0.000104	0.00034	CcSEcCtD
Valproic Acid—Diarrhoea—Pamidronate—osteoporosis	0.000104	0.000339	CcSEcCtD
Valproic Acid—Skin disorder—Estradiol—osteoporosis	0.000103	0.000338	CcSEcCtD
Valproic Acid—Hyperhidrosis—Estradiol—osteoporosis	0.000103	0.000337	CcSEcCtD
Valproic Acid—Rash—Ethinyl Estradiol—osteoporosis	0.000103	0.000337	CcSEcCtD
Valproic Acid—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000103	0.000336	CcSEcCtD
Valproic Acid—Headache—Ethinyl Estradiol—osteoporosis	0.000102	0.000335	CcSEcCtD
Valproic Acid—Hypersensitivity—Zoledronate—osteoporosis	0.000102	0.000333	CcSEcCtD
Valproic Acid—Vomiting—Risedronate—osteoporosis	0.000101	0.000331	CcSEcCtD
Valproic Acid—Rash—Risedronate—osteoporosis	0.0001	0.000328	CcSEcCtD
Valproic Acid—Dermatitis—Risedronate—osteoporosis	0.0001	0.000328	CcSEcCtD
Valproic Acid—Dizziness—Pamidronate—osteoporosis	0.0001	0.000327	CcSEcCtD
Valproic Acid—Headache—Risedronate—osteoporosis	9.97e-05	0.000326	CcSEcCtD
Valproic Acid—Asthenia—Zoledronate—osteoporosis	9.91e-05	0.000324	CcSEcCtD
Valproic Acid—Hypersensitivity—Conjugated Estrogens—osteoporosis	9.8e-05	0.000321	CcSEcCtD
Valproic Acid—Pruritus—Zoledronate—osteoporosis	9.78e-05	0.00032	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Estradiol—osteoporosis	9.7e-05	0.000317	CcSEcCtD
Valproic Acid—Nausea—Ethinyl Estradiol—osteoporosis	9.7e-05	0.000317	CcSEcCtD
Valproic Acid—Insomnia—Estradiol—osteoporosis	9.63e-05	0.000315	CcSEcCtD
Valproic Acid—Vomiting—Pamidronate—osteoporosis	9.62e-05	0.000315	CcSEcCtD
Valproic Acid—Paraesthesia—Estradiol—osteoporosis	9.56e-05	0.000313	CcSEcCtD
Valproic Acid—Asthenia—Conjugated Estrogens—osteoporosis	9.55e-05	0.000312	CcSEcCtD
Valproic Acid—Rash—Pamidronate—osteoporosis	9.54e-05	0.000312	CcSEcCtD
Valproic Acid—Dermatitis—Pamidronate—osteoporosis	9.53e-05	0.000312	CcSEcCtD
Valproic Acid—Dyspnoea—Estradiol—osteoporosis	9.49e-05	0.000311	CcSEcCtD
Valproic Acid—Headache—Pamidronate—osteoporosis	9.48e-05	0.00031	CcSEcCtD
Valproic Acid—Somnolence—Estradiol—osteoporosis	9.47e-05	0.00031	CcSEcCtD
Valproic Acid—Diarrhoea—Zoledronate—osteoporosis	9.45e-05	0.000309	CcSEcCtD
Valproic Acid—Nausea—Risedronate—osteoporosis	9.45e-05	0.000309	CcSEcCtD
Valproic Acid—Pruritus—Conjugated Estrogens—osteoporosis	9.41e-05	0.000308	CcSEcCtD
Valproic Acid—Dyspepsia—Estradiol—osteoporosis	9.37e-05	0.000307	CcSEcCtD
Valproic Acid—Decreased appetite—Estradiol—osteoporosis	9.26e-05	0.000303	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Estradiol—osteoporosis	9.19e-05	0.000301	CcSEcCtD
Valproic Acid—Fatigue—Estradiol—osteoporosis	9.18e-05	0.0003	CcSEcCtD
Valproic Acid—Dizziness—Zoledronate—osteoporosis	9.14e-05	0.000299	CcSEcCtD
Valproic Acid—Constipation—Estradiol—osteoporosis	9.11e-05	0.000298	CcSEcCtD
Valproic Acid—Pain—Estradiol—osteoporosis	9.11e-05	0.000298	CcSEcCtD
Valproic Acid—Diarrhoea—Conjugated Estrogens—osteoporosis	9.1e-05	0.000298	CcSEcCtD
Valproic Acid—Nausea—Pamidronate—osteoporosis	8.99e-05	0.000294	CcSEcCtD
Valproic Acid—Dizziness—Conjugated Estrogens—osteoporosis	8.8e-05	0.000288	CcSEcCtD
Valproic Acid—Vomiting—Zoledronate—osteoporosis	8.79e-05	0.000287	CcSEcCtD
Valproic Acid—Feeling abnormal—Estradiol—osteoporosis	8.78e-05	0.000287	CcSEcCtD
Valproic Acid—Rash—Zoledronate—osteoporosis	8.71e-05	0.000285	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Estradiol—osteoporosis	8.71e-05	0.000285	CcSEcCtD
Valproic Acid—Dermatitis—Zoledronate—osteoporosis	8.7e-05	0.000285	CcSEcCtD
Valproic Acid—Headache—Zoledronate—osteoporosis	8.66e-05	0.000283	CcSEcCtD
Valproic Acid—Vomiting—Conjugated Estrogens—osteoporosis	8.46e-05	0.000277	CcSEcCtD
Valproic Acid—Urticaria—Estradiol—osteoporosis	8.46e-05	0.000277	CcSEcCtD
Valproic Acid—Abdominal pain—Estradiol—osteoporosis	8.42e-05	0.000275	CcSEcCtD
Valproic Acid—Body temperature increased—Estradiol—osteoporosis	8.42e-05	0.000275	CcSEcCtD
Valproic Acid—Rash—Conjugated Estrogens—osteoporosis	8.39e-05	0.000274	CcSEcCtD
Valproic Acid—Dermatitis—Conjugated Estrogens—osteoporosis	8.38e-05	0.000274	CcSEcCtD
Valproic Acid—Headache—Conjugated Estrogens—osteoporosis	8.34e-05	0.000273	CcSEcCtD
Valproic Acid—Nausea—Zoledronate—osteoporosis	8.21e-05	0.000269	CcSEcCtD
Valproic Acid—Nausea—Conjugated Estrogens—osteoporosis	7.9e-05	0.000259	CcSEcCtD
Valproic Acid—Hypersensitivity—Estradiol—osteoporosis	7.85e-05	0.000257	CcSEcCtD
Valproic Acid—Asthenia—Estradiol—osteoporosis	7.64e-05	0.00025	CcSEcCtD
Valproic Acid—Pruritus—Estradiol—osteoporosis	7.53e-05	0.000247	CcSEcCtD
Valproic Acid—Diarrhoea—Estradiol—osteoporosis	7.29e-05	0.000238	CcSEcCtD
Valproic Acid—Dizziness—Estradiol—osteoporosis	7.04e-05	0.00023	CcSEcCtD
Valproic Acid—Vomiting—Estradiol—osteoporosis	6.77e-05	0.000222	CcSEcCtD
Valproic Acid—Rash—Estradiol—osteoporosis	6.71e-05	0.00022	CcSEcCtD
Valproic Acid—Dermatitis—Estradiol—osteoporosis	6.71e-05	0.000219	CcSEcCtD
Valproic Acid—Headache—Estradiol—osteoporosis	6.67e-05	0.000218	CcSEcCtD
Valproic Acid—Nausea—Estradiol—osteoporosis	6.33e-05	0.000207	CcSEcCtD
Valproic Acid—HDAC2—Signaling Pathways—PSMA5—osteoporosis	2.49e-05	0.000214	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PSMA2—osteoporosis	2.49e-05	0.000214	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—MGLL—osteoporosis	2.47e-05	0.000211	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—CYP19A1—osteoporosis	2.47e-05	0.000211	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—IL6—osteoporosis	2.46e-05	0.000211	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ACP5—osteoporosis	2.43e-05	0.000208	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—ADCY5—osteoporosis	2.43e-05	0.000208	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PKM—osteoporosis	2.42e-05	0.000207	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—FDPS—osteoporosis	2.42e-05	0.000207	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—GPX1—osteoporosis	2.42e-05	0.000207	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—TPI1—osteoporosis	2.39e-05	0.000205	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—ADCY5—osteoporosis	2.36e-05	0.000202	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CALCA—osteoporosis	2.32e-05	0.000199	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—MYC—osteoporosis	2.32e-05	0.000198	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—POMC—osteoporosis	2.31e-05	0.000198	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—TGFB1—osteoporosis	2.31e-05	0.000198	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ATIC—osteoporosis	2.3e-05	0.000197	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PNP—osteoporosis	2.3e-05	0.000197	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.3e-05	0.000197	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PGLS—osteoporosis	2.3e-05	0.000197	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GPD2—osteoporosis	2.3e-05	0.000197	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.27e-05	0.000194	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—TPI1—osteoporosis	2.26e-05	0.000194	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TGFB1—osteoporosis	2.26e-05	0.000194	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—P4HB—osteoporosis	2.25e-05	0.000193	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—MTHFR—osteoporosis	2.23e-05	0.000191	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GAPDH—osteoporosis	2.21e-05	0.000189	CbGpPWpGaD
Valproic Acid—CYP1A2—Biological oxidations—POMC—osteoporosis	2.19e-05	0.000188	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CA2—osteoporosis	2.19e-05	0.000188	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—OXCT1—osteoporosis	2.19e-05	0.000188	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MTHFR—osteoporosis	2.17e-05	0.000186	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—ADCY5—osteoporosis	2.16e-05	0.000185	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—CYP19A1—osteoporosis	2.16e-05	0.000185	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—GPX1—osteoporosis	2.15e-05	0.000184	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—RAP1A—osteoporosis	2.15e-05	0.000184	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—IDH2—osteoporosis	2.15e-05	0.000184	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—MGLL—osteoporosis	2.14e-05	0.000183	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ENO1—osteoporosis	2.13e-05	0.000183	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—P4HB—osteoporosis	2.13e-05	0.000182	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KL—osteoporosis	2.11e-05	0.000181	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PSMA2—osteoporosis	2.1e-05	0.00018	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PSMA5—osteoporosis	2.1e-05	0.00018	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PNP—osteoporosis	2.1e-05	0.00018	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ATIC—osteoporosis	2.1e-05	0.00018	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—IDH2—osteoporosis	2.1e-05	0.00018	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—CYP19A1—osteoporosis	2.1e-05	0.00018	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GAPDH—osteoporosis	2.09e-05	0.000179	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—ESR1—osteoporosis	2.08e-05	0.000178	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PKM—osteoporosis	2.07e-05	0.000177	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—FDPS—osteoporosis	2.07e-05	0.000177	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TGFB1—osteoporosis	2.07e-05	0.000177	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IRS2—osteoporosis	2.07e-05	0.000177	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—RAP1A—osteoporosis	2.03e-05	0.000174	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CYP27A1—osteoporosis	2.02e-05	0.000173	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—ADCY5—osteoporosis	2.02e-05	0.000173	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.02e-05	0.000173	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—GPX1—osteoporosis	2.01e-05	0.000172	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—MTHFR—osteoporosis	1.99e-05	0.00017	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP27A1—osteoporosis	1.97e-05	0.000169	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ACP5—osteoporosis	1.96e-05	0.000168	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GPD2—osteoporosis	1.96e-05	0.000168	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PGLS—osteoporosis	1.96e-05	0.000168	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CA2—osteoporosis	1.96e-05	0.000168	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—OXCT1—osteoporosis	1.96e-05	0.000168	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ACP5—osteoporosis	1.92e-05	0.000164	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—MGLL—osteoporosis	1.91e-05	0.000163	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.88e-05	0.000161	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—MTHFR—osteoporosis	1.85e-05	0.000159	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—TPI1—osteoporosis	1.83e-05	0.000156	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—IDH2—osteoporosis	1.82e-05	0.000156	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IRS1—osteoporosis	1.8e-05	0.000154	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.8e-05	0.000154	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PNP—osteoporosis	1.79e-05	0.000154	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ATIC—osteoporosis	1.79e-05	0.000154	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CA2—osteoporosis	1.79e-05	0.000153	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—OXCT1—osteoporosis	1.79e-05	0.000153	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—TPI1—osteoporosis	1.78e-05	0.000153	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—POMC—osteoporosis	1.78e-05	0.000153	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—ADCY5—osteoporosis	1.76e-05	0.000151	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—GPX1—osteoporosis	1.76e-05	0.00015	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—IL6—osteoporosis	1.74e-05	0.000149	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—MGLL—osteoporosis	1.74e-05	0.000149	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ENO1—osteoporosis	1.74e-05	0.000149	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—P4HB—osteoporosis	1.72e-05	0.000147	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—ADCY5—osteoporosis	1.71e-05	0.000147	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PSMA5—osteoporosis	1.71e-05	0.000147	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PSMA2—osteoporosis	1.71e-05	0.000147	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP27A1—osteoporosis	1.71e-05	0.000146	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—GPX1—osteoporosis	1.71e-05	0.000146	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CYP19A1—osteoporosis	1.71e-05	0.000146	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IL6R—osteoporosis	1.69e-05	0.000145	CbGpPWpGaD
Valproic Acid—CYP3A4—Biological oxidations—POMC—osteoporosis	1.69e-05	0.000145	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GAPDH—osteoporosis	1.68e-05	0.000144	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—P4HB—osteoporosis	1.68e-05	0.000144	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ACP5—osteoporosis	1.66e-05	0.000142	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ADCY5—osteoporosis	1.65e-05	0.000142	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GAPDH—osteoporosis	1.65e-05	0.000141	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ENO1—osteoporosis	1.64e-05	0.000141	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.64e-05	0.000141	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—RAP1A—osteoporosis	1.64e-05	0.000141	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.64e-05	0.00014	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—IDH2—osteoporosis	1.62e-05	0.000139	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MYC—osteoporosis	1.62e-05	0.000139	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—MTHFR—osteoporosis	1.62e-05	0.000139	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PSMA2—osteoporosis	1.62e-05	0.000139	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PSMA5—osteoporosis	1.62e-05	0.000139	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TGFB1—osteoporosis	1.62e-05	0.000138	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—RAP1A—osteoporosis	1.6e-05	0.000137	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SPP1—osteoporosis	1.6e-05	0.000137	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PKM—osteoporosis	1.6e-05	0.000137	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—FDPS—osteoporosis	1.6e-05	0.000137	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—POMC—osteoporosis	1.59e-05	0.000136	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—MTHFR—osteoporosis	1.58e-05	0.000135	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—TPI1—osteoporosis	1.55e-05	0.000132	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CA2—osteoporosis	1.53e-05	0.000131	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—OXCT1—osteoporosis	1.53e-05	0.000131	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.53e-05	0.000131	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GPD2—osteoporosis	1.51e-05	0.00013	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PGLS—osteoporosis	1.51e-05	0.00013	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—MGLL—osteoporosis	1.49e-05	0.000127	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ACP5—osteoporosis	1.48e-05	0.000127	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—POMC—osteoporosis	1.48e-05	0.000127	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—IDH2—osteoporosis	1.48e-05	0.000127	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.47e-05	0.000125	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—P4HB—osteoporosis	1.45e-05	0.000124	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IRS2—osteoporosis	1.45e-05	0.000124	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GAPDH—osteoporosis	1.43e-05	0.000122	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—LEP—osteoporosis	1.42e-05	0.000121	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.4e-05	0.00012	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ADCY5—osteoporosis	1.39e-05	0.000119	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.39e-05	0.000119	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CYP19A1—osteoporosis	1.39e-05	0.000119	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—RAP1A—osteoporosis	1.39e-05	0.000119	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GPX1—osteoporosis	1.39e-05	0.000119	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PNP—osteoporosis	1.38e-05	0.000119	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ATIC—osteoporosis	1.38e-05	0.000119	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—TPI1—osteoporosis	1.38e-05	0.000118	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ACP5—osteoporosis	1.35e-05	0.000116	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ESR1—osteoporosis	1.35e-05	0.000116	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.34e-05	0.000114	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ENO1—osteoporosis	1.33e-05	0.000114	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CYP19A1—osteoporosis	1.31e-05	0.000113	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PSMA2—osteoporosis	1.31e-05	0.000112	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PSMA5—osteoporosis	1.31e-05	0.000112	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—P4HB—osteoporosis	1.3e-05	0.000111	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ENO1—osteoporosis	1.3e-05	0.000111	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—POMC—osteoporosis	1.3e-05	0.000111	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—MTHFR—osteoporosis	1.28e-05	0.00011	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PSMA5—osteoporosis	1.28e-05	0.000109	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PSMA2—osteoporosis	1.28e-05	0.000109	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GAPDH—osteoporosis	1.27e-05	0.000109	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—IDH2—osteoporosis	1.26e-05	0.000108	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IRS1—osteoporosis	1.26e-05	0.000108	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—POMC—osteoporosis	1.26e-05	0.000108	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—TPI1—osteoporosis	1.26e-05	0.000108	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—RAP1A—osteoporosis	1.24e-05	0.000106	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IL6—osteoporosis	1.22e-05	0.000104	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—POMC—osteoporosis	1.22e-05	0.000104	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.21e-05	0.000104	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.19e-05	0.000102	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL6R—osteoporosis	1.19e-05	0.000102	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—P4HB—osteoporosis	1.18e-05	0.000101	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CA2—osteoporosis	1.18e-05	0.000101	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—OXCT1—osteoporosis	1.18e-05	0.000101	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IGF1—osteoporosis	1.17e-05	0.0001	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GAPDH—osteoporosis	1.16e-05	9.94e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ACP5—osteoporosis	1.16e-05	9.9e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—MGLL—osteoporosis	1.15e-05	9.83e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.14e-05	9.78e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ADCY5—osteoporosis	1.14e-05	9.72e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GPX1—osteoporosis	1.13e-05	9.69e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—RAP1A—osteoporosis	1.13e-05	9.68e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ENO1—osteoporosis	1.12e-05	9.62e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PSMA2—osteoporosis	1.11e-05	9.48e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PSMA5—osteoporosis	1.11e-05	9.48e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.08e-05	9.26e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—MYC—osteoporosis	1.08e-05	9.26e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—TPI1—osteoporosis	1.08e-05	9.21e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ADCY5—osteoporosis	1.07e-05	9.2e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GPX1—osteoporosis	1.07e-05	9.16e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CYP19A1—osteoporosis	1.06e-05	9.08e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—MTHFR—osteoporosis	1.04e-05	8.94e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.04e-05	8.88e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—POMC—osteoporosis	1.02e-05	8.77e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—P4HB—osteoporosis	1.01e-05	8.65e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MYC—osteoporosis	1e-05	8.6e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ENO1—osteoporosis	1e-05	8.58e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—TGFB1—osteoporosis	1e-05	8.58e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GAPDH—osteoporosis	9.92e-06	8.5e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PSMA2—osteoporosis	9.88e-06	8.46e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PSMA5—osteoporosis	9.88e-06	8.46e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—MTHFR—osteoporosis	9.88e-06	8.46e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.86e-06	8.44e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—IDH2—osteoporosis	9.76e-06	8.36e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—RAP1A—osteoporosis	9.66e-06	8.27e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP27A1—osteoporosis	9.17e-06	7.86e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ENO1—osteoporosis	9.14e-06	7.83e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PSMA2—osteoporosis	9.01e-06	7.71e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PSMA5—osteoporosis	9.01e-06	7.71e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP19A1—osteoporosis	8.98e-06	7.69e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ACP5—osteoporosis	8.92e-06	7.64e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ADCY5—osteoporosis	8.67e-06	7.42e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GPX1—osteoporosis	8.64e-06	7.39e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ADCY5—osteoporosis	8.47e-06	7.25e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GPX1—osteoporosis	8.44e-06	7.23e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.43e-06	7.22e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—POMC—osteoporosis	8.35e-06	7.15e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—TPI1—osteoporosis	8.3e-06	7.1e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP19A1—osteoporosis	8.01e-06	6.86e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—MTHFR—osteoporosis	7.97e-06	6.82e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—POMC—osteoporosis	7.9e-06	6.76e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ENO1—osteoporosis	7.81e-06	6.69e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—P4HB—osteoporosis	7.8e-06	6.68e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—MTHFR—osteoporosis	7.79e-06	6.67e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PSMA5—osteoporosis	7.7e-06	6.59e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PSMA2—osteoporosis	7.7e-06	6.59e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GAPDH—osteoporosis	7.66e-06	6.56e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IL6—osteoporosis	7.55e-06	6.46e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—RAP1A—osteoporosis	7.46e-06	6.39e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ADCY5—osteoporosis	7.34e-06	6.28e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GPX1—osteoporosis	7.31e-06	6.26e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP19A1—osteoporosis	7.31e-06	6.26e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MYC—osteoporosis	7.03e-06	6.02e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TGFB1—osteoporosis	7.01e-06	6.01e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—MTHFR—osteoporosis	6.75e-06	5.78e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ADCY5—osteoporosis	6.55e-06	5.61e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GPX1—osteoporosis	6.53e-06	5.59e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—POMC—osteoporosis	6.37e-06	5.46e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP19A1—osteoporosis	6.24e-06	5.35e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—POMC—osteoporosis	6.23e-06	5.33e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ENO1—osteoporosis	6.03e-06	5.16e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—MTHFR—osteoporosis	6.02e-06	5.16e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ADCY5—osteoporosis	5.97e-06	5.11e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GPX1—osteoporosis	5.95e-06	5.09e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PSMA2—osteoporosis	5.94e-06	5.09e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PSMA5—osteoporosis	5.94e-06	5.09e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—MTHFR—osteoporosis	5.49e-06	4.7e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—POMC—osteoporosis	5.4e-06	4.62e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL6—osteoporosis	5.28e-06	4.53e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ADCY5—osteoporosis	5.1e-06	4.37e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GPX1—osteoporosis	5.08e-06	4.35e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.82e-06	4.13e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—POMC—osteoporosis	4.82e-06	4.12e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—MTHFR—osteoporosis	4.69e-06	4.02e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—POMC—osteoporosis	4.39e-06	3.76e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ADCY5—osteoporosis	3.94e-06	3.37e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GPX1—osteoporosis	3.92e-06	3.36e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—POMC—osteoporosis	3.75e-06	3.21e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—MTHFR—osteoporosis	3.62e-06	3.1e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—POMC—osteoporosis	2.9e-06	2.48e-05	CbGpPWpGaD
